Supplementary Fig. 10: WGD in primary and metastatic cancers.
From: Genome doubling shapes the evolution and prognosis of advanced cancers
The rate of WGD in primary and metastatic samples in the indicated cancer types in the prospective cohort is shown (number of primary and metastatic samples indicated in parentheses; error bars are the binomial CIs). Asterisks reflect statistically significant differences as in Fig. 3b.
